Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hao T. Du"'
Autor:
Erkan Kiris, Jonathan E Nuss, Stephanie M Stanford, Laura M Wanner, Lisa Cazares, Michael F Maestre, Hao T Du, Glenn Y Gomba, James C Burnett, Rick Gussio, Nunzio Bottini, Rekha G Panchal, Christopher D Kane, Lino Tessarollo, Sina Bavari
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129264 (2015)
There is an urgent need to develop novel treatments to counter Botulinum neurotoxin (BoNT) poisoning. Currently, the majority of BoNT drug development efforts focus on directly inhibiting the proteolytic components of BoNT, i.e. light chains (LC). Al
Externí odkaz:
https://doaj.org/article/60298f029db949189b12f9558abf609f
Autor:
Lino Tessarollo, Krishna P. Kota, James C. Burnett, Hao T. Du, Rekha G. Panchal, Jonathan E. Nuss, Brian D. Peyser, Laura M. Wanner, Glenn Y. Gomba, Erkan Kiris, Rick Gussio, Christopher D. Kane, Sina Bavari
Publikováno v:
Neurotoxicity Research. 27:384-398
Botulinum neurotoxins (BoNTs), the causative agents of botulism, are potent inhibitors of neurotransmitter release from motor neurons. There are currently no drugs to treat BoNT intoxication after the onset of the disease symptoms. In this study, we
Autor:
Glenn Y. Gomba, Rick Gussio, James C. Burnett, Sina Bavari, Christopher D. Kane, Michael F. Maestre, Jonathan E. Nuss, Stephanie M. Stanford, Lisa H. Cazares, Lino Tessarollo, Nunzio Bottini, Hao T. Du, Rekha G. Panchal, Laura M. Wanner, Erkan Kiris
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129264 (2015)
PLoS ONE
PLoS ONE
There is an urgent need to develop novel treatments to counter Botulinum neurotoxin (BoNT) poisoning. Currently, the majority of BoNT drug development efforts focus on directly inhibiting the proteolytic components of BoNT, i.e. light chains (LC). Al